TP53 and acute lymphoblastic leukemia: Moreover, the result of Cabezas et al. study on 173 Caucasian ALL cases revealed that patients harboring TP53 Pro/Pro or Pro/Arg genotype had a higher risk of resistance to apoptotic-based agents [373].